FOR IMMEDIATE RELEASE
INDIANAPOLIS – BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana’s significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies.
GLP-1 therapies, developed and delivered through the relentless efforts of Indiana’s researchers and companies, have emerged as vital tools in managing obesity and diabetes, offering new hope to millions worldwide.
Nationwide, more than 38 million (1) Americans are living with diabetes, with obesity being linked to as many as 53 percent of new cases of type 2 diabetes each year (2). In Indiana, more than 12% of the adult population is living with diabetes, with an estimated 31,200 more adults expected to be diagnosed every year, (3) and Indiana’s obesity rate is higher than the national average and has been increasing steadily over the past 20 years. As of 2021, 36.3 percent, more than two-thirds of adults in Indiana were obese and 33.3% were overweight. This places Indiana 12th in the nation for obesity (4)—making the demand for effective solutions even more critical.
“Indiana’s contributions to GLP-1 therapies are also setting new standards in the global fight against obesity and metabolic diseases,” said Vince Wong, CEO of BioCrossroads. “The 2024 Indiana Life Sciences Summit is a compelling platform to highlight the pivotal role Indiana has played in bringing transformative innovation to address some of the most challenging unmet needs in healthcare and to gain insights into future developments that will benefit patients, not only in Indiana, but throughout the world. By bringing together industry leaders, researchers, and patients, we aim to foster collaboration and inspire further breakthroughs in diabetes and obesity care.”
A highlight of the event will be the presentation of the prestigious August M. Watanabe Life Sciences Champion of the Year Award, honoring exceptional contributions to life sciences in Indiana. Named in memory of Dr. August “Gus” Watanabe, a visionary in the industry, this award recognizes outstanding achievements and significant contributions in life sciences.
Secure your front row seat for this impactful discussion. Register now and join BioCrossroads at the 2024 Indiana Life Sciences Summit. For more information and to register, please visit BioCrossroads.
____________________________________________________________
(1) CDC National Diabetes Statistics Report
(2) American Heart Association Obesity and Diabetes Link
(3) American Diabetes Association. The Burden of Diabetes in Indiana
(4) Richard M. Fairbanks Foundation, Indiana’s Obesity Epidemic
Transforming Healthcare, Indiana’s Role in Revolutionizing Diabetes and Obesity Management
Save the Date: November 7, 2024
Location: Biltwell Event Center, Indianapolis
Time: 9:00 AM – 3:30 PM
Thank you to our generous sponsors for their continued support.
###
About BioCrossroads
Established as a catalyst to advance, grow, and invest in Indiana’s life sciences sector, BioCrossroads is a branded initiative of the Central Indiana Corporate Partnership (CICP). It supports the region’s existing enterprises and encourages new business development. The initiative fosters public-private collaboration by uniting a diverse range of academic, industry, and philanthropic stakeholders, all collectively focused on advancing Indiana’s life sciences sector. Committed to supporting the growth of capital investments and talent development, BioCrossroads provides support to both existing and new life sciences enterprises, including the Indiana Health Information Exchange, OrthoWorx, and the Indiana Biosciences Research Institute. BioCrossroads champions the advancement of cutting-edge research and development, plays a crucial role in building and nurturing a robust talent pipeline, and is dedicated to establishing Indiana as a thriving hub for life sciences manufacturing. To learn more about BioCrossroads, visit biocrossroads.com.
Media Contact: Amanda Decker, Director of Communications, BioCrossroads
adecker@biocrossroads.com
317.332.8561
